2m 2m 2m 2m 2m 2m 2m
HAOXI HEALTH-A (HAO)
NASDAQ
$1.14+$0.04 (+4.13%)
Price as of Jun 03, 2026 7:36 PM EDT- $3.1MMarket Cap
- -99.42%1-Year Change
- Advertising AgenciesIndustry
HAOXI HEALTH-A (HAO)
$1.14+$0.04 (+4.13%)
Annual
Quarterly
06/30/2025 | 06/30/2024 | ||
|---|---|---|---|
Income Statement | |||
Total Operating Revenue | 32.8M -32.39% | 48.5M N/A | |
Cost of Revenue | 31.9M -30.35% | 45.8M N/A | |
Gross Profit | 927,750 -66.27% | 2.8M N/A | |
Sales and Marketing Expense | 50,176 +20.58% | 41,613 N/A | |
Research and Development Expense | -79,544 -0.55% | -79,985 N/A | |
Depreciation and Amortization Expense | 77,144 +630.05% | 10,567 N/A | |
Total Operating Expenses | 2.9M +183.38% | 1.0M N/A | |
Operating Profit | -2.0M -216.46% | 1.7M N/A | |
Interest Income | 363,312 +377.44% | 76,096 N/A | |
Interest Expense | -45,956 +11.58% | -41,186 N/A | |
Interest Income and Expense and Net | 317,356 +809.07% | 34,910 N/A | |
Total Nonoperating Income and Expense | 6.1M +34,049.92% | 18,001 N/A | |
Income before Taxes | 4.1M +139.01% | 1.7M N/A | |
Income Taxes | 270,744 -38.96% | 443,582 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | |
Net Income | 3.9M +200.13% | 1.3M N/A | |
Net Income from Continuing Operations Applicable to Common | 4.1M +139.01% | 1.7M N/A | |
Basic EPS and Net Income | 1.66 +4,050.00% | 0.04 N/A | |
Diluted EPS and Net Income | 1.32 +3,200.00% | 0.04 N/A | |
Basic Weighted Average Shares | 2.3M -92.37% | 30.6M N/A | |
Diluted Weighted Average Shares | 2.4M -92.17% | 30.6M N/A | |
Balance Sheet | |||
Cash and Cash Equivalents | 8.6M +29.49% | 6.7M N/A | |
Short-Term Investments | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 8.6M +29.49% | 6.7M N/A | |
Total Current Assets | 19.6M +27.47% | 15.4M N/A | |
Accumulated Depreciation | 46,854 +57.73% | 29,705 N/A | |
Property and Plant and Equipment and Net | 108,899 -14.08% | 126,743 N/A | |
Total Long-Term Assets | 2.0M +1,470.70% | 126,743 N/A | |
Total Assets | 21.6M +39.27% | 15.5M N/A | |
Income Taxes Payable | 1.3M +25.15% | 1.0M N/A | |
Total Short-Term Debt | 1.6M +84.01% | 873,998 N/A | |
Total Current Liabilities | 3.9M +0.48% | 3.9M N/A | |
Total Long-Term Debt | 333,819 +10.65% | 301,678 N/A | |
Total Long-Term Liabilities | 333,819 -9.30% | 368,043 N/A | |
Total Liabilities | 4.2M -0.37% | 4.2M N/A | |
Retained Earnings | 4.6M +536.04% | 723,207 N/A | |
Total Stockholders Equity | 17.4M +54.16% | 11.3M N/A | |
Total Shares Outstanding | 2.2M -93.16% | 32.2M N/A | |
Cash Flow | |||
Cash from Operating Activities | -3.4M +349.20% | -747,576 N/A | |
Capital Expenditures | N/A N/A | 55,367 N/A | |
Cash from Investing Activities | -3.6M +14.41% | -3.1M N/A | |
Dividends Paid | N/A N/A | N/A N/A | |
Cash from Financing Activities | 8.9M -4.52% | 9.3M N/A | |
Financials Ratio | |||
Gross Margin | 2.83% N/A | N/A N/A | |
Operating Margin | -6.10% N/A | N/A N/A | |
Return on Assets | 20.90% N/A | N/A N/A | |
Return on Equity | 27.06% N/A | N/A N/A | |
Revenue Growth | -32.39% N/A | N/A N/A | |
Current Ratio | 5.05 N/A | N/A N/A | |
Cash Ratio | 2.22 N/A | N/A N/A | |
Debt-to-Equity Ratio | 0.11 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.09 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow